Dr Parth Nagda
| Dr Parth Nagda | |
|---|---|
| Born | |
| 💼 Occupation | |
| Known for | Psychopharmacology, substance use disorders, clinical psychiatry research |
Parth Nagda is an Indian psychiatrist and academic researcher whose work focuses on psychopharmacology, substance use disorders, consultation–liaison psychiatry, and neuropsychiatric case studies.[1]
He has authored multiple peer-reviewed journal articles and case reports and has been cited in mainstream media for commentary on mental health topics including sleep, anxiety, and stress.[2]
Education
Nagda completed his medical education in India and later specialised in psychiatry. His academic interests include clinical psychiatry, adverse effects of psychotropic medications, and public mental health education.[3]
Career
Nagda is involved in clinical psychiatric practice and academic research. He has collaborated with psychiatrists and researchers across India and has published original research articles, reviews, and case reports in national and international peer-reviewed journals.[4] He currently practises in Navi Mumbai.
Research interests
- Psychopharmacology and adverse drug reactions
- Alcohol dependence and withdrawal syndromes
- Consultation–liaison psychiatry
- Electroconvulsive therapy
- Neuropsychiatric disorders and dementia
Media contributions
Nagda has been cited as a mental health expert in Indian media outlets including The Indian Express, Financial Express, BBC Marathi, Times Now, Happiest Health, HealthShots, Mid-Day, and ABP Live, where he has commented on mental health awareness, sleep science, anxiety, stress, and emotional well-being.[5]
Public engagement
Nagda supports evidence-based mental health awareness and contributes to public understanding of psychiatry through academic writing, interviews, and health education initiatives.
Selected publications
- Nagda P, Halder A, Ravindran NP, Joshi A. Endoxifen: The Diverse Molecule – A Case Series. International Journal of Psychiatry Research. 2025;7(1):33–35.
- Nagda P, Harshe D, Halder A, Ravindran NP. Study of socio-economic, biochemical and clinical predictors of delirium tremens. Annals of Indian Psychiatry. 2024;8(1):52–60.
- Harshe D, Nagda P, Gore S. Delirium after abrupt discontinuation of clozapine. Asian Journal of Psychiatry. 2020;53:102235.
References
- ↑ Nagda, P (2025). "Endoxifen: The Diverse Molecule – A Case Series". International Journal of Psychiatry Research. 7 (1): 33–35. doi:10.33545/26648962.2025.v7.i1a.83.
- ↑ "Why sleep deprivation affects mental health". The Indian Express. 2023.
- ↑ Nagda, P (2024). "Study of socio-economic, biochemical and clinical predictors of delirium tremens". Annals of Indian Psychiatry. 8 (1): 52–60. doi:10.4103/aip.aip_193_2 (inactive 3 January 2026).
- ↑ Harshe, D; Nagda P (2020). "Delirium after abrupt discontinuation of clozapine". Asian Journal of Psychiatry. 53. doi:10.1016/j.ajp.2020.102235. PMID 32590141 Check
|pmid=value (help). Unknown parameter|article-number=ignored (help) - ↑ "Managing anxiety in the digital age". BBC Marathi. 2022.
This article "Parth Nagda" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Parth Nagda. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
